Parkinson disease
Conditions
Interventions
Patients were allocated rTSMS first group. PD patients with camptocormia were administered a single trial of rTSMS (a train of 40 stimuli) followed one week later by sham treatment.
Patients were allo
Sponsors
Department of Clinical Research, Tokushima National Hospital, National Hospital Organization
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Eligibility criteria included a clinical diagnosis of PD with a disease severity rating of stage 3-4 on the Hoehn and Yahr scale confirmed camptocormia, stable medication use, medical clearance for participation, and willingness to participate in treatment and outcome testing.
Exclusion criteria
Exclusion criteria: Exclusion criteria were current participation in any other behavioral or pharmacologic study or debilitating conditions that would impede full participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Thoracolumbar spine flexion angle in the standing position | — |
Secondary
| Measure | Time frame |
|---|---|
| Thoracolumber spine flexion angle in the seated position | — |
Countries
Japan
Contacts
Public ContactTakao Mitsui
Tokushima National Hospital, National Hospital Organization Department of Clinical Research
Outcome results
None listed